Bridge, Julia A.
ProPath,
United States
2025 Rank: 113194
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3443 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113194 | 111904 |
| Total Cites | 750 | 810 |
| H-index | 12 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 8 | 9 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 68 | 71 |
| Number of Single+First+Last Authored Papers | 133 | 133 |
| Total Cites to Single+First+Last Authored Papers | 216 | 223 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 594 | 631 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
7.41%
|
|
Bridge, Julia A.
University of Nebraska Medical Center,
United States
2024 Rank: 99240
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3271 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 99240 | 107629 |
| Total Cites | 759 | 813 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 65 | 73 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 194 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 605 | 639 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
6.64%
|
|
Bridge, Julia A.
ProPath,
United States
2023 Rank: 78993
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2867 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78993 | 85257 |
| Total Cites | 821 | 895 |
| H-index | 14 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 81 | 83 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 221 | 228 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 646 | 686 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.30 |
| Self-Citation Percentage |
8.27%
|
|
Bridge, Julia A.
University of Nebraska Medical Center,
United States
2022 Rank: 57170
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2165 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57170 | 60089 |
| Total Cites | 893 | 990 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 105 | 115 |
| Number of Single+First+Last Authored Papers | 131 | 131 |
| Total Cites to Single+First+Last Authored Papers | 272 | 295 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 687 | 744 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
9.80%
|
|
Bridge, Julia A.
University of Nebraska Medical Center,
United States
2021 Rank: 61853
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2235 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61853 | 65215 |
| Total Cites | 1276 | 1398 |
| H-index | 17 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 134 | 140 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 362 | 381 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1027 | 1106 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
8.73%
|
|
Bridge, Julia A.
The Nebraska Medical Center,
United States
2020 Rank: 83223
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2908 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83223 | 92603 |
| Total Cites | 866 | 948 |
| H-index | 14 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 73 | 74 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 230 | 239 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 715 | 764 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
8.65%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.